Welcome to our dedicated page for Cabbacis news (Ticker: CABI), a resource for investors and traders seeking the latest updates and insights on Cabbacis stock.
Cabbacis Inc (CABI) delivers enterprise software solutions and digital transformation services through cutting-edge technologies like blockchain and AI. This dedicated news hub provides investors and industry observers with essential updates about the company's strategic developments.
Access official press releases and curated news covering financial results, technology innovations, and strategic partnerships. Our repository simplifies tracking CABI's market position, product launches, and leadership changes within the competitive enterprise software sector.
Discover updates about the company's subscription models, licensing agreements, and operational advancements. Content is organized for quick scanning while maintaining technical accuracy, serving both casual investors and professional analysts.
Bookmark this page for streamlined access to CABI's evolving story. Check regularly for verified updates about digital integration initiatives and emerging technology applications that shape modern business solutions.
Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco manufacturer, has filed its Annual Report for fiscal year 2024. The company, focused on developing harm-reduction products under the iBlend™ brand, reported increased losses with:
- Net loss from operations of $956,464 in 2024 (vs $380,174 in 2023)
- Total net loss of $915,886 in 2024 (vs $379,068 in 2023)
- Negative EPS of $0.15 (vs -$0.07 in 2023)
As a development-stage company, CABI generated no revenue in 2024. The company reports significant progress in product development, including their ongoing clinical trial of iBlend™ reduced-nicotine cigarettes, which is over 50% complete.
Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco product manufacturer and plant biotech company, has received DTC Eligibility approval from the Depository Trust Company. This development follows the company's previous listing approval on the OTCQB under the symbol 'CABI'.
DTC, a subsidiary of the Depository Trust and Clearing (DTCC), manages electronic clearing and settlement of publicly traded companies' shares. The DTC Eligibility status enables electronic clearing and settlement of Cabbacis shares, expediting stock and cash receipt processes while simplifying trading and share transfers between brokerage companies.
Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco product manufacturer and plant biotech company, has received approval for listing its common stock on the OTCQB Venture Market. The OTCQB, operated by OTC Markets Group, serves entrepreneurial and development stage companies among its 12,000+ securities. The company expects this listing to enhance shareholder liquidity, transparency, and expand its investor reach.
